Abstract. Using a flow cytometry-based parasite growth inhibition assay (GIA) and an antibody-dependent cellular inhibition (ADCI) assay, we have assessed the differential effect and interaction of monocytes, immune sera, and purified immunoglobulins from Kenyan adults on the growth of Plasmodium falciparum parasites in vitro. We found that monocytes from 14 different normal, healthy, non-malaria-exposed donors had varying effects on parasite growth, i.e., inhibition or enhancement of parasitemia, suggesting heterogeneity in anti-parasitic activities of monocytes from individual donors. Twenty-two serum samples collected from clinically immune adults from western Kenya inhibited growth of P. falciparum after 48 hr in culture. In contrast, all IgG preparations, except one, purified from the same serum samples enhanced parasite growth. In ADCI experiments, of the 22 purified IgG samples used, 11 showed ADCI activities with specific growth inhibition (SGI) of more than 10%, with the highest at 27.6%, and the remaining 11 IgG samples had an SGI of less than 10%. Our results also showed that the ratio of IgG1 to IgG3 antibodies, as determined by an indirect immunofluorescence assay, was higher in the high ADCI response group than in the low response group, suggesting that a higher concentration of IgG1 antibodies with a higher IgG1/IgG3 ratio might be associated with ADCI activities. The present study has resulted in the development of simple, reproducible flow cytometry-based GIA and ADCI assays, and also provides baseline information for further investigation of the role of ADCI activity in naturally acquired immune protection against malaria.
Development of acquired protective immunity against malaria in human is epidemiologically well documented, but the characteristics of protective immunity are not fully understood. Available immunologic evidence suggests that both humoral and cell-mediated immune responses are essential components of this immunity. 1, 2 The development of continuous cultivation of the blood-stage of Plasmodium falciparum by Trager and Jensen 3 provided the basis for the development of the growth inhibition assay (GIA) for assessing the effect of antibodies and other immune factors on parasite invasion and development in erythrocytes. Subsequent in vitro studies revealed that purified IgGs from immune adults resident in malaria-endemic areas inhibit the invasion and development of parasites in vitro. 4, 5 This approach has led to the identification of several vaccine candidate antigens from the blood stage of P. falciparum. [6] [7] [8] Involvement of antibodies in immune protection against P. falciparum blood stages has been established by passive antibody transfer studies in humans. In these studies, several investigators have found that passive transfer of IgGs from immune adults to nonimmune infected children causes a marked decrease in P. falciparum parasitemias 1, [9] [10] [11] [12] Investigations from the laboratory of Druilhe identified the cooperation of antibodies with monocytes in protection against malaria. [13] [14] [15] In these studies, pooled sera and purified antibodies from west African immune adults were found to inhibit parasite growth in the presence of monocytes via antibody-dependent cellular inhibition (ADCI), while the purified antibodies alone enhanced parasite growth. Most importantly, the in vitro ADCI activity correlated with clinical protection as demonstrated by passive transfer of the purified immune IgGs in a parasite strain-independent manner. 12, 15 It was further shown that the ADCI activity is dependent on IgG binding to monocytes via the Fc␥ RII receptor, is triggered by a merozoite surface component, is mediated by the soluble factors released from monocytes, and inhibits the development of parasites from the ring to the schizont stage. In this study, only tumor necrosis factor was shown to be involved in the ADCI defense mechanism. 16 These studies led to the conclusion that ADCI activity is one of the protective mechanisms against the asexual stages of P. falciparum. However, there has been a controversy about the ADCI mechanism since one investigation conducted in Papua New Guinea failed to repeat the earlier observations. 17 Questions that have been raised regarding inconsistent observations pertain to whether the assay conditions are crucial to reproduce the in vitro experimental system or epidemiologic features of these two study sites and the nature of immune responses have contributed to different outcomes.
As a part of vaccine-related field studies, we are delineating the characteristics of naturally acquired protective immunity in western Kenya, a region of east Africa with high malaria transmission. Therefore, identification of in vitro responses associated with clinical protective immunity in western Kenya is essential for the vaccine development process and will also facilitate preclinical and clinical evaluation of candidate vaccine antigens in this endemic area. As a first step in the investigation of the in vitro responses associated with clinical protection, we adapted a flow cytometry-based parasite enumerating system into GIA and ADCI assays. This was followed by examination of the differential effect and interaction of monocytes and Kenyan immune sera on parasite growth. This study allowed us to answer the following interrelated questions. 1) Are the flow cytometry-based GIA and ADCI assays reproducible? 2) Do the monocytes from different normal donors show heterogeneity in antiparasitic activity? 3) Is there a difference in GIA activities between the sera and the corresponding purified IgG from Kenyan immune adults? 4) What is the profile of GIA and ADCI activities in the purified IgGs from the immune adults? 5) Do the IgG levels and subclass pattern in the immune adults correlate with in vitro ADCI activities. The present study provides baseline information for further investigation of the role of ADCI in naturally acquired protection against malaria in western Kenya.
MATERIALS AND METHODS
Serum collection and IgG purification. Healthy control sera from non-malaria-exposed donors Ͼ 25 years old were obtained from the blood bank of the Centers for Disease Control and Prevention (CDC) (Atlanta, GA). These sera were pooled and also used for routine parasite culture. Twenty-two serum samples from adults Ͼ 25 years old were collected in 1995 from men and women (pregnant women were excluded) living in the Asembo Bay area of western Kenya. Both men and women were randomly chosen for this study. Thick films were made at the time of serum collection and no parasites were detected by light microscopy. These immune adults had spent all or at least most of their lives in this P. falciparum-holoendemic area. Malaria is transmitted throughout the year and entomologic inoculation rates as high as 300 infected bites per year have been measured in this area. 18 The study was approved by the Institutional Ethical Review Boards of both CDC and the Kenya Medical Research Institute, and informed consent was obtained from all study participants. Five hundred microliters of serum from each sample were aliquoted, heated at 56ЊC for 30 min to inactivate complement, and stored at Ϫ20ЊC for the GIA assay. The IgGs were purified from the remaining sera using ammonium sulfate (Sigma Chemical Co., St. Louis, MO) precipitation followed by DEAE (Pierce, Rockford, IL) batch purification according to methods described elsewhere. 19 The IgG purity was estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and staining the gel with Coomassie blue and quantified by the Bradford method (Bio-Rad Laboratories, Hercules, CA). The IgG preparations were dialyzed in RPMI 1640 medium and concentrated to 10 mg/ml. The IgG fraction was then filtered through 0.22-m Millex-GS filters (Millipore, Bedford, MA) and stored at Ϫ20ЊC for GIA and ADCI assays.
Preparation of monocytes. Monocytes were isolated from 14 healthy Americans (CDC blood bank) who had never experienced malaria or been to a malaria-endemic area, and had not used antibiotics within the past month. Both male and female volunteers Ͼ 25 years old were randomly chosen for this study. Heparinized peripheral blood was taken by venipuncture, kept at 4ЊC, and processed within 2 hr. Mononuclear cells were separated on Fico/Lite-LymphoH (Atlanta Biologicals, Norcross, GA). The cells were then washed three times with serum-free RPMI 1640 medium, and the mononuclear cells (lymphocytes and monocytes) were resuspended in cell culture medium (RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum [FBS] , 100 units/ml of penicillin, 100 g/ml of streptomycin, and 200 mM glutamine) and plated in plastic tissue culture Petri dishes (Nunc, Roskilde, Denmark) coated with autologous plasma. After incubation for 2.5 hr at 37ЊC in a CO 2 incubator, the Petri dishes were washed 15 times with cold RPMI 1640 medium containing 10% FBS and the adherent monocytes were removed with a cell scraper (Costar Corporation, Cambridge, MA). The recovered monocyte suspensions were washed once with RPMI 1640 medium supplemented with 10% FBS and generally were of 90% purity and 95% viability as determined by the nonspecific esterase stain and by trypan blue exclusion, respectively. The cells were suspended in cell culture medium, and cultivated with 100 ng/ml of recombinant human interferon-␥ (rhIFN-␥) 16 (BioSource International Camarillo, CA) for 48 hr in flatbottom, 96-well plates (Costar Corporation).
The GIA and ADCI assays. The laboratory-adapted FC27 strain of P. falciparum was used in this study. Bloodstage parasites were cultured as described 3 in RPMI 1640 medium supplemented with 10% heat-inactivated Oϩ human serum, 1 g/ml of gentamicin, 36 M hypoxanthine, 31 mM HEPES, and 25 mM sodium bicarbonate. The in vitro proliferative rate of the FC27 strain parasite per cycle is approximately 10-fold. The GIA and ADCI assays were both performed in flat-bottom, 96-well tissue culture plates containing 150 l of culture medium per well. The effects of sera, purified IgGs, monocytes, and monocytes plus IgGs on the P. falciparum parasite growth were assessed in 48-hr cultures without medium replacement. The parasite cultures were asynchronous with an initial parasitemia of 0.5% (Ͼ 50% schizonts) and a hematocrit of 1%. To assess the influence of monocytes on parasite growth, 8 ϫ 10 4 rhIFN-␥-activated monocytes were used in each well. To test the effect of antibodies on parasite growth, serum samples from immune adults and normal donors were added to cultures at a final concentration of 10%, and the corresponding purified IgGs were added at a final concentration of 1 mg/ml, respectively. For the ADCI assay, the purified IgGs at a final concentration of 1 mg/ml and 8 ϫ 10 4 rhIFN-␥-activated monocytes were added to each well. All tests and controls were performed in duplicate. At the end of the 48-hr culture of parasites, parasitemia was assessed by flow cytometry.
Assessment of parasitemia by flow cytometry. We have adapted the method of Heyde and others 20 to enumerate erythrocytes containing viable malaria parasites in the presence of monocytes and differentiation of parasite stages. Cocultures of infected erythrocytes and monocytes are incubated with the vital dye hydroethidine (HE), which is converted by metabolically active cells to ethidium. The interaction of ethidium and nucleic acids of parasites allows a distinction between infected erythrocytes and uninfected erythrocytes using flow cytometry. To differentiate parasite stages, erythrocytes infected with schizonts were first concentrated by gelatin floatation, 21 and then put into continuous culture. The infected erythrocytes harvested after 18 hr of continuous culture contained mostly ring/trophozoite-stage parasites, and the infected erythrocytes harvested after 48 hr contained predominantly schizonts. These infected erythrocytes were incubated with HE and the erythrocytes infected with rings/trophozoites were discriminated from schizonts based on the fluorescence intensity of the infected erythrocytes. For HE staining, a stock solution of HE (10 mg/ml in dimethylsulfoxide) (Polysciences, Inc., Warrington, PA) was prepared and stored at Ϫ20ЊC. The culture medium was removed from each well of parasite culture plates. Two hundred microliters of HE diluted 1:200 in phosphate-buffered saline (PBS) was added to each well and incubated for 20 min at 37ЊC in the dark. The cells were then washed twice with PBS by centrifugation of the plate at 1,000 rpm for 2 min, and were resuspended in a final volume of 1 ml of PBS in the tubes for fluorescence-activated cell sorter (FACS) analysis. Flow cytometric data acquisition and analysis were done on a FACScan (Becton-Dickinson, San Jose, CA). The detectors of forward, side scatter, and FL2 were set in logarithmic mode, and 10,000 cells were used for data acquisition. Both infected and uninfected erythrocytes were gated in the analysis and the percentage of parasitemia ([number of infected erythrocytes/total erythrocytes] ϫ 100) was determined using the LYSIS II program (Becton Dickinson).
Indirect immunofluorescence assay (IFA). Titers of antibody against blood-stage parasites in the 22 IgG samples from Kenyan were determined by an IFA. 22 Briefly, 10 l of two-fold serial diluted purified IgGs (10 mg/ml) were added to multi-spot antigen slides containing air-dried P. falciparum (FC27 strain) including all blood stages. The slides were allowed to incubate in a moist chamber at 37ЊC for 30 min. They were then washed three times with PBS, and fluorescein isothiocyanate-conjugated mouse anti-human total IgG, and subclasses IgG1, IgG2, IgG3, and IgG4 (Zymed Laboratories, Inc., San Francisco, CA) were added. After incubation and washing, antibody titers were determined by fluorescence microscopy. Purified IgG from normal donors was used as a control.
Expression of results and statistical analysis. The mean of parasitemias in duplicate was calculated, followed by determining specific growth inhibition (SGI) to evaluate the effect of monocytes alone, antibodies alone (GIA), and antibodies plus monocytes (ADCI) on the growth of P. falciparum. The SGIs were calculated as follows: 1) SGI of monocytes alone GIA ϭ 100 ϫ [1 Ϫ {% mean parasitemia with monocytes/% mean parasitemia without monocytes}]; 2) SGI of antibody GIA ϭ 100 ϫ [1 Ϫ {% mean parasitemia with test serum (or IgG)/% mean parasitemia with normal serum (or IgG)}]; 3) SGI of ADCI ϭ 100 ϫ [1 Ϫ {(% mean parasitemia with monocytes and test IgG/% mean parasitemia with test IgG)/(% mean parasitemia with monocytes and control IgG/% mean parasitemia with control IgG)}]. The Student's t-test was used for statistical analysis.
RESULTS
Establishment of the flow cytometry-based GIA and ADCI. Assessment of the GIA and ADCI assays is dependent on accurate determination of end point parasitemia. To determine whether uninfected erythrocytes, infected erythrocytes, and monocytes can be distinguished from each other, and whether parasite stages can be differentiated, we examined the mixtures of these cell populations with different parasitemias after staining with the vital dye HE by flow cytometry. Based on the forward scatter (size), monocytes were segregated from the populations of uninfected and infected erythrocytes. Figure 1 shows that uninfected erythrocytes (first peak) had a lower fluorescence intensity than infected erythrocytes, which allowed distinction of infected from uninfected erythrocytes. Based on the intensity of fluorescence among infected erythrocytes, the erythrocytes infected with rings/trophozoites ( Figure 1A) were further differentiated from schizonts ( Figure 1B) . To confirm measurement accuracy of parasitemias by flow cytometry, Giemsastained thin films of the parasite cultures were used as a standard. Figure 2 shows that the parasitemias determined by flow cytometry were consistent with the parasitemias counted by Giemsa-stained films (r ϭ 0.978). In addition, the difference in parasitemias between duplicate wells measured by flow cytometry was less than 10%, demonstrating the reproducibility of the flow cytometry-based parasite enumerating procedure.
Heterogeneity in anti-parasitic activities of monocytes from normal donors. Peripheral blood adherent cells were isolated from 14 healthy donors who had never been exposed to malaria. Monocytes pre-incubated with rhIFN-␥ for 48 hr were used to evaluate their effect on the growth of P. The monocytes from donor 249 inhibited parasite growth, but the levels of inhibition were different at different time points. The inhibition of parasite growth was observed in donor 446 at one of the three time points. Difference in GIA activities between sera and purified IgGs from the Kenyan immune adults. As shown in Table  2 , all western Kenya sera inhibited growth of P. falciparum after 48 hr in culture. The range of inhibitory activities were from a low SGI of 7.6% to a high SGI of 93.4%. In contrast to the sera, most of the IgG purified from the same sera enhanced parasite growth (Table 2) . Only one IgG preparation had direct inhibition of parasite growth at an SGI of 16.6%; the remaining 21 samples of purified IgG from immune adults enhanced parasite growth at the SGI levels of Ϫ8.3% to Ϫ66%. There was no correlation between the SGIs from individuals' serum GIAs and purified IgG GIAs.
The ADCI activities in the purified IgGs from Kenyan immune adults. Because monocytes from donor 134 showed no parasite growth inhibitory activities in three separate experiments (Table 1) , we chose this donor for further study of ADCI function using the purified IgG from Kenyan immune adults. We found ADCI activities consistently in the rhIFN-␥-activated monocytes from donor 134. To avoid day to day variation, we conducted ADCI experiments for all of the 22 purified IgG samples on the same day with monocytes from donor 134. Table 2 shows ADCI activities of the 22 purified IgG samples from the Kenyan immune adults. We observed that among the 22 IgG samples, 11 showed ADCI activities with SGIs more than 10%, with highest at 27.6%. The remaining 11 IgG samples had SGIs less than 10%.
Correlation between ADCI activities and IFA responses. The total IgG and IgG subclasses against bloodstage parasites were determined in the 22 IgG samples using the IFA. The IgG antibody responses were detected in all the samples, with IgG1 and IgG3 predominating. The range of total IgG, IgG1, and IgG3 titers were from 1/400 to 1/ 3,200, 1/100 to 1/1,600, and 1/400 to 1/3,200, respectively. The geometric mean titers of total IgG, IgG1, and IgG3 were 1/1,200, 1/470, and 1/1,130, respectively. Subclasses IgG2 and IgG4 were not detected at the 1:100 dilution. To determine whether IgG1 and IgG3 antibody responses were associated with ADCI activities, we divided the ADCI activities of the 22 samples into low response and high response groups based on their SGI levels. Levels of total IgG, IgG1, IgG3, and the ratio of IgG1 to IgG3 were compared between these two response groups. As shown in Table 3 , there was no significant difference in the total IgG level between the low response and high response groups. However, differences in the IgG1 and IgG3 antibody levels between these two response groups were observed, although there was no statistical significance. Compared with the low ADCI activity group, the high ADCI response group had higher IgG1 levels and lower IgG3 levels. Further comparison of the ratio of IgG1 to IgG3 showed that the ratio in the high ADCI response group (0.929) was higher than that in the low activity group (0.825) (P ϭ 0.001). Taken together, these results indicated that ADCI activities may not only require higher levels of IgG1 antibody but also may depend on the relative balance between IgG1 and IgG3 antibody levels.
DISCUSSION
Understanding the characteristics of naturally acquired immunity in different epidemiologic settings is essential for * Specific growth inhibition (SGI) is expressed relative to normal controls (0%) that received normal pooled sera or normal purified IgG, and taken into account the possible inhibition induced by monocytes and antibodies alone (calculation is described in the Materials and Methods). Percentages without a negative value represent inhibition of parasite growth. Percentages with a negative value represent enhancement of parasitemia.
† 10% heat-inactivated sera added. ‡ 1mg/ml of purified IgGs added. † The ADCI activities of the 22 samples were divided into low response and high response based on their specific growth inhibition (SGI) levels. A low response was an SGI Ͻ10% and a high response was an SGI Ն 10%.
‡ Total IgG and subclass titers were transformed to natural logarithms. § Subclass titers were first transformed to natural logarithms; ratios were then calculated.
vaccine development as well as for testing vaccine candidates for immunogenicity and protective efficacy. Previous studies of naturally acquired immunity, which revealed ADCI as an important immune mechanism, were conducted in west Africa and Papua New Guinea. [13] [14] [15] 17 These studies provided conflicting observations on the ability of purified immune IgGs to inhibit parasite growth in an ADCI assay. An impressive aspect of the west African investigation was the passive transfer study, in which immune IgGs from clinically immune adults decreased parasitemia in non-immune infected children. The reason for the differences in the observations in Papua New Guinea and west Africa is not known, but differences in assay conditions, epidemiologic features of the two study sites, and the nature of immune responses may have contributed to different outcomes. The present study was designed to establish a flow cytometrybased parasite enumerating system, to investigate heterogenicity of monocytes from normal donors, and to determine the GIA and ADCI activities in serum and purified IgGs from residents of an endemic area of western Kenya with different epidemiologic features and clinical manifestations as compared with prior studies. Prior studies in west Africa and Papua New Guinea used conventional microscopy in the GIA and ADCI. [13] [14] [15] 17 Our studies have incorporated the use of flow cytometry in these in vitro assays. We have found that the flow cytometry-based methods accurately measure parasitemias and different parasite stages. This methodology is reproducible and allows the investigation of the differential effects and the interaction of monocytes and antibodies on P. falciparum growth in vitro.
We first examined the effects of the rhIFN-␥-activated monocytes from different normal donors on parasite growth in vitro. We found that among 14 normal donors, monocytes from seven donors inhibited parasite growth in vitro, four enhanced parasitemia, and three did not significantly affect the parasite during culture in vitro. It was also noted that the monocytes collected from the same donor at different time points had different effects on parasite growth. Previous studies reported that IFN-␥-activated monocyte-derived macrophages (MDMs) kill P. falciparum parasite in vitro. [23] [24] [25] However, in another study it has been shown that the MDMs activated by IFN-␥ accelerate parasite development and enhancement of parasitemias. 20 Although IFN-␥-activated monocytes, not MDMs, were used in our study, the results point out that the effects of the cells on parasite growth vary from donor to donor. It is likely that the heterogeneity of anti-malarial activities of monocytes/MDMs observed in vitro is related to inherent genetic differences and/or different in vivo activation status. Therefore, the involvement of the monocytes in in vivo malarial parasite clearance may vary in individuals, depending on the differences in genetic and/or immune status of the host.
The GIA assay has been used to measure the survival of malaria parasites after exposure to antibody and other immune factors in vitro. In this study, we have been able to compare the antimalarial effect of heat-inactivated sera and corresponding purified IgGs from clinically immune Kenyan adults. The results of our study show that the use of sera consistently inhibited parasite growth, whereas most of the corresponding purified IgGs enhanced parasitemia. One of the factors involved in anti-parasitic activity in the serum samples may be residual antimalarial drug(s) circulating at the time of blood draw. To investigate this, we examined the levels of chloroquine/quinine, and sulfa compounds (sulfadoxine, sulfalene, and sulfamethoxazole) in these serum samples. Results of the experiment showed that the samples contained less than 10 ng/ml of chloroquine/quinine in 21 of 22 samples, and below the detection levels of sulfalene. The levels of sulfadoxine were also below detection levels in seven of 22 samples, and in the remaining samples ranged from 0.5 g/ml to 1.5 g/ml. These varying levels of antimalarials in the serum may explain the inhibitory effects of serum on parasite growth. It is also possible that inhibition of parasite growth mediated by the immune sera from malaria-endemic areas is due to other non-antibody factors, such as lipid peroxides. 26 We found that purified IgGs from Kenyan immune adults enhanced parasitemia, except one sample that inhibited parasite growth at a lower level. Our results are in agreement with the study conducted by Bouharoun-Tayoun and others, in which a pool of IgGs from clinically immune west Africans enhanced the parasite growth in vitro. 15 Compared with the ADCI activities of Ͼ 50% SGI in west Africa, we found that among the 22 tested IgGs from Kenyan immune adults, only five had ADCI activities with SGIs greater than 20%. It is possible that the discrepancies in the results of ADCI assays are due to the differences in experimental design (pooled IgGs were used in west African study) and the repertoire of anti-malarial antibodies. Since the ADCI activity is dependent on IgG binding to monocytes via their Fc␥ RII receptor, 16 it is likely that the discrepancy of ADCI activities in different studies is related to the monocytes from donors with different backgrounds. It has been shown that a single amino acid change in the extracellular domain of Fc␥ RIIA receptor influences the antibody-mediated monocyte function. 27 In addition, because Fc␥ RII receptor expression on the monocytes may be associated with the activation of the effector cells, it is also possible that the use of the monocytes from healthy donors with different age and sex is related to the discrepancy of ADCI activities in different studies. This explanation is supported by the evidence from our study, where monocytes from donors 134 (a 51-year-old woman) and 246 (a 33-year-old man) mediated varying levels of ADCI activities, although the same antibody preparation was used. In view of the possibility that the ADCI function can be influenced not only by antibodies but also by monocyte activation in vivo and allelic forms of Fc␥ RIIA receptor on monocyte, we propose that monocytes from malaria-exposed donors in different endemic areas should be used in studies of ADCI activity to better understand the role of this mechanism in naturally acquired protection against malaria.
In addition, an important methodologic point for the ADCI assay is the start parasitemia used for the assay. For instance, we have found that very low level start parasitemia (0.1-0.2%) does not induce ADCI function, while a higher level parasitemia (0.5% parasitemia, with Ͼ 50% schizonts) gave consistent ADCI activities. These results suggest that parasite load and merozoites released from schizonts are crucial in triggering the cooperation between monocytes and antibodies.
It has been previously shown that the pool of the cytophilic IgG1 and IgG3 antibodies obtained from clinically immune subjects from west Africa exhibit ADCI activities. 28 However, the contribution of IgG1 and IgG3 antibodies in ADCI activities was not examined. The data presented in this study show that although IgG1 levels were lower than IgG3 in general, the high ADCI response group had a higher IgG1 level and a lower IgG3 level compared with the low ADCI activity group. Most importantly, the ratio of IgG1 to IgG3 in the high ADCI response group was higher than that of the low activity group, suggesting that the ADCI activity required a higher level of IgG1 antibody with a relative balance between IgG1 and IgG3 in overall antibody levels. It is known that the IgG subclasses, IgG1 and IgG3, are associated with specific functional attributes, particularly the ability to promote Fc␥ receptor-mediated activities. It is also known that IgG1 has a higher affinity to Fc␥ receptors on monocytes; 29 thus it is likely that the specific IgG1 antibodies may be more inhibitory in ADCI activity. The observation of importance of the IgG1 to IgG3 ratio in ADCI activity in immune adults in our study would also suggest that IgG3 antibodies may interfere with the protective IgG1 antibodies by competing for the same antigens/epitopes on parasites. This observation is supported by our recent study in which only IgG1 antibodies to merozoite surface protein-1 19kD were found to be associated with protection against parasitemia in young children. 30 Overall, the present study suggests that differences in assay conditions, epidemiologic features of the study sites, and the nature of immune responses contribute to different outcomes in different studies. While antibodies alone have been shown to inhibit the invasion/development of parasite into red blood cells in several studies, our and other studies [13] [14] [15] [16] have elucidated the combined effect of antibodies and monocytes in parasite growth inhibition. While these anti-parasitic effects are easy to separate in vitro, it is possible that a combination of these events may be involved in vivo. It is also possible that the host's ability to mount adequate and specific responses may depend on immune activation due to the presence of other concomitant infections. The results from this study also offer a view, at least for the ADCI mechanism where inhibitory effects of up to 30% were observed, that naturally acquired immunity does not lead to sterile protection. We propose that the presence of low-level circulating parasitemia in immune adults modifies the balance of protective IgG1 and IgG3 antibodies, and influences the activation status of monocytes. Differences in the quality versus quantity of antibodies, monocytes, and parasite load can be expected to influence premunition status at an individual level.
